Profitability Ratios
| Ratio |
Value |
| GP Margin |
76.7% |
| EBIT Margin |
31.2% |
| EBITDA Margin |
34.0% |
| Operating Margin |
31.2% |
| Pretax Margin |
33.8% |
| Cont. Ops Margin |
26.8% |
| Net Margin |
26.8% |
| Bottom Line Margin |
26.8% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
7.98 |
| Quick Ratio |
6.84 |
| Solvency Ratio |
1.756 |
| Cash Ratio |
5.03 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
3.35 |
| Forward PEG |
3.35 |
| Price/Book |
13.08 |
| Price/Sales |
14.77 |
| Price/FCF |
72.03 |
| Price/Op Cash Flow |
49.61 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0000 |
| Debt/Equity |
0.0000 |
| Debt/Capital |
0.0000 |
| Long-Term Debt/Capital |
0.0000 |
| Financial Leverage |
1.15 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
1.22 |
| Operating Cash Flow Ratio |
2.451 |
| Operating Cash Flow/Sales |
29.8% |
| Free Cash Flow/Operating Cash Flow |
68.9% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
0.00 |
| Interest Coverage |
0.0000 |
| Short-Term Operating Cash Flow Coverage |
0.00 |
| Operating Cash Flow Coverage |
0.00 |
| Capital Expenditure Coverage |
3.21 |
| Dividend + Capital Expenditure Coverage |
1.09 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
66.9039% |
| Dividend Yield |
1.2153% |
| Dividend Yield % |
1.2153% |
| Dividend Per Share |
1.1822 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
6.59 |
| EPS |
1.767 |
| Debt/Share |
0.0000 |
| Cash/Share |
4.02 |
| Book Value/Share |
7.44 |
| Tangible BV/Share |
7.17 |
| Equity/Share |
7.44 |
| Operating Cash Flow/Share |
1.961 |
| Capital Expenditure/Share |
0.610 |
| FCF/Share |
1.351 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.793 |
| Earnings Before Tax/EBIT |
1.085 |
| Price/Fair Value |
13.08 |
| Debt/Market Cap |
0.0000 |
| Effective Tax Rate |
20.7% |
| Enterprise Value Multiple |
41.59 |
IRMD - IRadimed Corporation